199 related articles for article (PubMed ID: 29938548)
1. CD10, TDAG51, CK20, AR, INSM1, and Nestin Expression in the Differential Diagnosis of Trichoblastoma and Basal Cell Carcinoma.
Leblebici C; Bambul Sığırcı B; Kelten Talu C; Koca SB; Huq GE
Int J Surg Pathol; 2019 Feb; 27(1):19-27. PubMed ID: 29938548
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of cytokeratin 15, TDAG51, cytokeratin 20 and androgen receptor in sclerosing adnexal neoplasms and variants of basal cell carcinoma.
Evangelista MT; North JP
J Cutan Pathol; 2015 Nov; 42(11):824-31. PubMed ID: 26016446
[TBL] [Abstract][Full Text] [Related]
3. [Application of immunohistochemical staining of bcl-2, Ber-EP4, CD10, CK20, and Ki-67 in differential diagnosis between trichoblastoma and basal cell carcinoma].
Zhang ZC; Hu J; Kong YY; Ren M; Cai X
Zhonghua Bing Li Xue Za Zhi; 2021 Apr; 50(4):376-381. PubMed ID: 33831998
[No Abstract] [Full Text] [Related]
4. Basaloid tumors in nevus sebaceus revisited: the follicular stem cell marker PHLDA1 (TDAG51) indicates that most are basal cell carcinomas and not trichoblastomas.
Sellheyer K; Cribier B; Nelson P; Kutzner H; Rütten A
J Cutan Pathol; 2013 May; 40(5):455-62. PubMed ID: 23489134
[TBL] [Abstract][Full Text] [Related]
5. Basaloid tumors arising from seborrheic keratosis: Malignant basal cell carcinoma or benign basaloid follicular hamartomatous proliferation?
Flordelis JO; Shen YC; Wu YH
J Cutan Pathol; 2020 Mar; 47(3):207-218. PubMed ID: 31682281
[TBL] [Abstract][Full Text] [Related]
6. Cytokeratin 20 expression in basaloid follicular hamartoma and infundibulocystic basal cell carcinoma.
Honarpisheh H; Glusac EJ; Ko CJ
J Cutan Pathol; 2014 Dec; 41(12):916-21. PubMed ID: 25353070
[TBL] [Abstract][Full Text] [Related]
7. Follicular stem cell marker PHLDA1 (TDAG51) is superior to cytokeratin-20 in differentiating between trichoepithelioma and basal cell carcinoma in small biopsy specimens.
Sellheyer K; Nelson P
J Cutan Pathol; 2011 Jul; 38(7):542-50. PubMed ID: 21352265
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of CD10 and Bcl2 expression in distinguishing cutaneous basal cell carcinoma from squamous cell carcinoma and seborrheic keratosis.
Gaballah MA; Ahmed RA
Pathol Res Pract; 2015 Dec; 211(12):931-8. PubMed ID: 26573127
[TBL] [Abstract][Full Text] [Related]
9. Anti-cytokeratin 20 staining of Merkel cells helps differentiate basaloid proliferations overlying dermatofibromas from basal cell carcinoma.
Mahmoodi M; Asad H; Salim S; Kantor G; Minimo C
J Cutan Pathol; 2005 Aug; 32(7):491-5. PubMed ID: 16008693
[TBL] [Abstract][Full Text] [Related]
10. CD10 for the distinct differential diagnosis of basal cell carcinoma and benign tumours of cutaneous appendages originating from hair follicle.
Sengul D; Sengul I; Astarci MH; Ustun H; Mocan G
Pol J Pathol; 2010; 61(3):140-6. PubMed ID: 21225496
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic utility of immunohistochemistry in distinguishing trichoepithelioma and basal cell carcinoma: evaluation using tissue microarray samples.
Tebcherani AJ; de Andrade HF; Sotto MN
Mod Pathol; 2012 Oct; 25(10):1345-53. PubMed ID: 22684216
[TBL] [Abstract][Full Text] [Related]
12. Does the panel of cytokeratin 20 and androgen receptor antibodies differentiate desmoplastic trichoepithelioma from morpheaform/infiltrative basal cell carcinoma?
Katona TM; Perkins SM; Billings SD
J Cutan Pathol; 2008 Feb; 35(2):174-9. PubMed ID: 18190441
[TBL] [Abstract][Full Text] [Related]
13. p40 in Conjunction With CK20 and E-Cadherin Distinguishes Primary Adnexal Neoplasms of the Skin.
Andruszkow JH; Oll M; Förster S; Knüchel R; Jäkel J
Appl Immunohistochem Mol Morphol; 2016 Jul; 24(6):414-21. PubMed ID: 26180934
[TBL] [Abstract][Full Text] [Related]
14. Cytokeratin 17 is highly sensitive in discriminating cutaneous lymphadenoma (a distinct trichoblastoma variant) from basal cell carcinoma.
Goyal A; Solus JF; Chan MP; Doyle LA; Schaffer A; Thakuria M; Horn TD; Duncan LM; Nazarian RM
J Cutan Pathol; 2016 May; 43(5):422-9. PubMed ID: 26968559
[TBL] [Abstract][Full Text] [Related]
15. Expression of CD10 in basal cell carcinoma.
Yada K; Kashima K; Daa T; Kitano S; Fujiwara S; Yokoyama S
Am J Dermatopathol; 2004 Dec; 26(6):463-71. PubMed ID: 15618927
[TBL] [Abstract][Full Text] [Related]
16. INSM1 Is More Sensitive and Interpretable than Conventional Immunohistochemical Stains Used to Diagnose Merkel Cell Carcinoma.
Lilo MT; Chen Y; LeBlanc RE
Am J Surg Pathol; 2018 Nov; 42(11):1541-1548. PubMed ID: 30080705
[TBL] [Abstract][Full Text] [Related]
17. Follicular induction and CK20+ Merkel cells overlying cutaneous focal mucinosis.
Chairatchaneeboon M; Elenitsas R; Nguyen JV
J Cutan Pathol; 2019 Mar; 46(3):195-198. PubMed ID: 30552701
[TBL] [Abstract][Full Text] [Related]
18. Bcl-2 and CD10 expression in the differential diagnosis of trichoblastoma, basal cell carcinoma, and basal cell carcinoma with follicular differentiation.
Córdoba A; Guerrero D; Larrinaga B; Iglesias ME; Arrechea MA; Yanguas JI
Int J Dermatol; 2009 Jul; 48(7):713-7. PubMed ID: 19570076
[TBL] [Abstract][Full Text] [Related]
19. Cytokeratins as markers of follicular differentiation: an immunohistochemical study of trichoblastoma and basal cell carcinoma.
Kurzen H; Esposito L; Langbein L; Hartschuh W
Am J Dermatopathol; 2001 Dec; 23(6):501-9. PubMed ID: 11801790
[TBL] [Abstract][Full Text] [Related]
20. CD34 and BerEP4 Are Helpful to Distinguish Basaloid Tricholemmoma From Basal Cell Carcinoma.
Turnbull N; Ghumra W; Mudaliar V; Vella J; Sanders DSA; Taibjee S; Carr R
Am J Dermatopathol; 2018 Aug; 40(8):561-566. PubMed ID: 29570129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]